Work

531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results

Year: 2015

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)30332-x

Authors: D. Migliorini, R. Vernet, M.C. Belkouch, P. Luy, S. Blaser, V. Ancrenaz, N. Blazek, N. Grandjean, J. Wasem, B. Janin, P. Harboe-Schmidt, J. Grogg, N. Bouche, N. Mach

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249394863

FWCI: 0.406

Cites:

Cited by: 4

Related to: 10